0001062993-24-006896.txt : 20240320
0001062993-24-006896.hdr.sgml : 20240320
20240320180821
ACCESSION NUMBER: 0001062993-24-006896
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Qamar Huma
CENTRAL INDEX KEY: 0002015296
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36751
FILM NUMBER: 24768879
MAIL ADDRESS:
STREET 1: C/O OCUGEN, INC.
STREET 2: 11 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocugen, Inc.
CENTRAL INDEX KEY: 0001372299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-328-4701
MAIL ADDRESS:
STREET 1: 11 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: HISTOGENICS CORP
DATE OF NAME CHANGE: 20060810
3
1
form3.xml
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
X0206
3
2024-03-18
0
0001372299
Ocugen, Inc.
OCGN
0002015296
Qamar Huma
C/O OCUGEN, INC.
11 GREAT VALLEY PARKWAY
MALVERN
PA
19355
0
1
0
0
Chief Medical Officer
Common Stock
1643
D
Exhibit List: Exhibit 24.1 - Power of Attorney
/s/ Huma Qamar
2024-03-20
EX-24.1
2
exhibit24-1.txt
POA
POWER OF ATTORNEY
Know all by these present, that I, the undersigned director
and/or officer of Ocugen, Inc., a Delaware corporation (the "Company"),
hereby constitute and appoint Shankar Musunuri and Michael Breininger as
my true and lawful attorneys-in-fact and agents, with full power to act,
together or each without the other, with full power of substitution and
resubstitution, for me and in my name, place and stead, in any and all
capacities:
(i) to execute and file for and on behalf of the undersigned
any reports on Forms 3, 4 and 5 (including any amendments thereto and any
successors to such Forms) with respect to ownership acquisition or
disposition of securities of the Company that the undersigned may be
required to file with the U.S. Securities and Exchange Commission (the "SEC")
in accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and the rules promulgated thereunder;
(ii) to execute and file for and on behalf of the undersigned any
voluntary filings under Section 16(a) of the Exchange Act;
(iii) to request electronic filing codes from the SEC by filing the
Form ID (including amendments thereto) and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to file
such reports electronically;
(iv) to prepare, file, and submit any documents or reports that
may be required under SEC Rule 144 to permit the undersigned to sell Company
common stock without registration under the Securities Act of 1933, as amended
(the "Securities Act") in reliance on Rule 144 as amended from time to time; or
(v) take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorneys-in-fact, may be of
benefit to, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such attorneys-in-fact may
approve in such attorneys-in-fact's discretion.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16(a) of the Exchange Act or the Securities Act. The
Company will use all reasonable efforts to apprise the undersigned of
applicable filing requirements for purposes of Section 16(a) of the Exchange
Act or the Securities Act.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect
to the undersigned's holdings and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact. This Power of Attorney
revokes and replaces any prior Power of Attorney executed by the
undersigned with respect to the ownership, acquisition or disposition of
securities of the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this March 8, 2024.
/s/ Huma Qamar
Signature
Huma Qamar
Print Name